FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:259-260 January 26, 1995 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Infectious diseases can be extremely variable in their manifestations, but human immunodeficiency virus (HIV) infection is notorious for its protean manifestations. One of these, the absence of any apparent progression of disease over a decade or more, is particularly intriguing. The average time from HIV infection to death is 10 years, but clinical and immunologic decline is generally evident much earlier. About 5 percent of infected people are characterized as having nonprogressive infection because they remain healthy and do not have the declining CD4+ lymphocyte counts that are evident in people with progressive disease.¹ Although we remain uncertain of their . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Caselli, E., Betti, M., Grossi, M. P., Balboni, P. G., Rossi, C., Boarini, C., Cafaro, A., Barbanti-Brodano, G., Ensoli, B., Caputo, A. (1999). DNA Immunization with HIV-1 tat Mutated in the trans Activation Domain Induces Humoral and Cellular Immune Responses Against Wild-Type Tat. J. Immunol. 162: 5631-5638 [Abstract] [Full Text]  
• Barouch, D. H., Santra, S., Steenbeke, T. D., Zheng, X. X., Perry, H. C., Davies, M.-E., Freed, D. C., Craiu, A., Strom, T. B., Shiver, J. W., Letvin, N. L. (1998). Augmentation and Suppression of Immune Responses to an HIV-1 DNA Vaccine by Plasmid Cytokine/Ig Administration. J. Immunol. 161: 1875-1882 [Abstract] [Full Text]  
• Zhang, C., Cui, Y., Houston, S., Chang, L.-J. (1996). Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals. Proc. Natl. Acad. Sci. USA 93: 14720-14725 [Abstract] [Full Text]  
• Clotet, B., Ruiz, L., Ibanez, A., Whyte, J., Dunkle, L. M., Farid, N. R., Ho, D. D., Cao, Y., Pantaleo, G., Fauci, A. S. (1995). Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection. NEJM 332: 1646-1648 [Full Text]  
• (1995). Clues from Long-Term HIV Survivors. AIDS Clin Care 1995: 5-5 [Full Text]